This post is sponsored by IMARC Research, Inc.
The key players in a clinical investigation are infamously made up of Sponsors, monitors, investigative sites, and patients. A fundamental part of the team is also the Institutional Review Board (IRB), as they oversee the conduct of clinical research. Per the FDA’s IRB information sheet, “IRBs are responsible for continuing review of ongoing research to ensure that the rights and welfare of human subjects are protected.” That’s a tall order!
To help all the key players in an investigation better understand the role and responsibilities of an IRB, we’ve put together an infographic cheat-sheet called: IRB’s 123’s.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
FDA has placed an enormous responsibility on institutional review boards. The rules that govern IRBs are clearly laid out in 21 CFR 56, which contains general standards for IRB:
- Composition
- Operation
- Responsibility
Check out the infographic and feel free to print our guide as a tool for your entire research team! After all — no matter what position you play on the clinical research team, we’re all responsible for protecting the rights and welfare of human subjects.
Let us know what you think! Any ideas for other tools? Comment below.
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
